Analyst Coverage

Josh Schimmer
Cantor Fitzgerald
Roanna Ruiz
Leerink Partners
Andreas Argyrides
Oppenheimer & Co.
Ryan Deschner
Raymond James
Kyle Bauser
Roth Capital Partners
Lachlan Hanbury-Brown
William Blair

ARS Pharmaceuticals is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding ARS Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of ARS Pharmaceuticals or its management. ARS Pharmaceuticals does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.